Tramadol, buy tramadol, antibiotics, Weight Loss drugs, weight loss herbs, weight loss herbal formula, weight loss, hair loss, hair growth, baldness, Rx Online, pharmaceuticals, DHEA, Lutein, Prescription, Prescription drug, prescription medications, hemoglobin.

DreamPharm Products:

Lutein-20||Herbs for headache, fever, and migraine || Milk thistle||Saw palmetto|| Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract|| Ginseng and Ginkgo||Hair Million|| DHEA||Coenzyme Q10|| Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.|| Weight loss herbal formula for menopause and pms||Ginkgo biloba|| Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver

Fatty acids resources:

Pathogen research abs 1 || Pathogen research abs 2 || Pathogen research abs 3 || Pathogen research abs 4 || Pathogen research abs 5 || Hormone and endocrine research abs 1 || Hormone and endocrine research abs 2 || Hormone and endocrine research abs 3 || Hormone and endocrine research abs 4 || Hormone and endocrine research abs 5 || Follicle and follicular cells research abs 1 || Interferon research abs 1 || Hemoglobin research abs

J Korean Med Sci. 2002 Jun;17(3):337-40.
Defective erythropoiesis in bone marrow is a mechanism of anemia in children with cancer.

Kim M, Lee J, Wu C, Cho S, Lee K.

Department of Pediatrics, College of Medicine, Korea University, Seoul, Korea.

Evaluation of the mechanism of anemia in cancer patients might help to select patients for the more efficient use of erythropoietin (EPO, a growth factor for erythroid precursor cells). For this, we investigated whether the production of EPO responds to anemia and the bone marrow responds to EPO appropriately, and whether chronic inflammation is inhibitory to erythropoiesis in anemic cancer children. Serum levels of EPO, soluble transferrin receptor (sTfR), tumor necrosis factor (TNF)-alpha, and erythrocyte sedimentation rate (ESR) in anemic cancer children were measured by enzyme-linked immunosorbent assay and then the correlation coefficients between those parameters and hemoglobin (Hb) were determined. Both in leukemia and in solid tumor patients, there were significant inverse correlations between Hb and EPO (leukemia: tau=-0.547, p<0.0001; solid tumor: tau=-0.591, p<0.0001), and between sTfR and EPO (leukemia: tau=-0.223, p<0.05; solid tumor: tau=-0.401, p<0.05). In contrast, sTfR showed a correlation with Hb in leukemia (tau=0.216, p<0.05) but not in solid tumor patients. sTfR was suppressed in 53% of anemic episodes of leukemia and 78% of those of solid tumor patients. Our results suggest that in cancer children, the EPO production is not defective and chronic inflammation is not inhibitory to erythropoiesis. Rather, the defective erythropoiesis itself is thought to be responsible for the anemia.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12068136&dopt=Abstract

J Korean Med Sci. 2002 Jun;17(3):341-7.
Survival benefits of lung cancer patients undergoing laser and brachytherapy.

Jang TW, Blackman G, George JJ.

Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea. jangts.kosinmed.or.kr

We aimed to compare the duration of survival among subjects receiving brachytherapy (BT) in combination with Nd:YAG laser therapy (LT), and those receiving LT or BT alone. The medical records of subjects who received endobronchial treatment for unresectable tracheobronchial malignancies between January 1997 and December 1999 in a single center were reviewed retrospectively. A total of 80 patients were evaluated. The overall symptomatic response rate after treatment was 86.5%. Median survival durations for the LT, BT, and combined therapy (CT) group were 111, 115, and 264 days, respectively. The survival duration was significantly longer in the CT group than in the BT group (p=0.0078), but the difference was not statistically significant between the CT and the LT group. The bronchoscopic finding of endobronchial polypoid lesion was associated with a longer survival time than extraluminal with compression type (p=0.0023) by univariate analysis. Other factors associated with the better prognosis included hemoglobin > or = 12.5 g/dL, serum albumin level > or = 37 g/L, and BT dose > or = 15 Gy at 1 cm distance. Of these factors, specific bronchoscopic findings, serum albumin level, CT modality, and dose of BT retained statistical significance in multivariate analysis. In conclusion, combined LT and BT is associated with increased patient survival compared with BT alone. Combined therapy may improve survival time in selected patients with endobronchial malignancies.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12068137&dopt=Abstract

J Arthroplasty. 2002 Jun;17(4 Suppl 1):125-8.
Transfusion options in total joint arthroplasty.

Keating EM, Ritter MA.

Center for Hip and Knee Surgery, St. Francis Hospital-Mooresville, Mooresville, Indiana 46158 , USA.

Concern about the safety of allogeneic blood transfusion, including the risk of viral infection and immunosuppression, has led to the development of transfusion options in total joint arthroplasty, including intraoperative and postoperative blood salvage, autologous donation, hemodilution, and the use of epoetin alfa. Intraoperative or postoperative blood salvage has been shown not to be cost-effective at our institution except in revision hip arthroplasties because not enough blood is collected. Autologous donation is not helpful. One third of patients undergoing joint arthroplasty have hemoglobin values between 10 and 13 g/dL preoperatively. The most efficient way to decrease allogeneic risk in these patients is epoetin alfa. Epoetin alfa decreases allogeneic risk to 12.9%, which is acceptable. Patients with preoperative hemoglobin >14 g/dL undergoing single total knee or total hip arthroplasty do not need anything because their allogeneic risk is minimal. 2002, Elsevier Science (USA).

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12068422&dopt=Abstract

Genetika. 2002 May;38(5):655-64.
[Gene-geographical variation and genetic differentiation in red-backed voles of the genus Clethrionomys (Rodentia, Cricetidae) in the Okhotskii region]

[Article in Russian]

Frisman LV, Kartavtseva IV, Pavlenko MV, Kostenko VA, Suzuki H, Ivasa M, Nakata K, Cherniavskii FB.

Soil Biology Institute, Russian Academy of Sciences, Vladivostok, 690022 Russia.

Thirteen enzyme systems and three nonenzyme proteins were electrophoretically analyzed in red-backed voles of the genus Clethrionomys. In total, 25 loci were interpreted. Gene-geographic variation was studied and indices of genetic variability and differentiation were determined. By the distribution of electrophoretic variants of hemoglobin, C. rutilus was shown to be divided into two geographical groups (northern and southern). A low level of genetic differentiation was revealed in the island isolates of C. rutilus and C. rufocanus. Separation of C. rufocanus, C. rex, and C. sicotanensis into a superspecies complex was confirmed. A study of differential G- and C-banding on C. rutilus and C. rufocanus chromosomes did not reveal intraspecific variation of autosomes. In these species, karyotypes of voles from Kamchatka Peninsula were studied for the first time. They appeared to be morphologically similar to the karyotypes continental voles by both autosomes and sex chromosomes.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12068550&dopt=Abstract

Eur J Haematol. 2002 Mar;68(3):150-6.
The Advia 120 red blood cells and reticulocyte indices are useful in diagnosis of iron-deficiency anemia.

Kotisaari S, Romppanen J, Penttila I, Punnonen K.

Department of Clinical Chemistry and Hematology, Kuopio University Hospital, Finland.

We have investigated the red blood cell (RBC) and reticulocyte indices of the Advia 120 hematology system in assessment of body iron stores as well as in diagnostics of iron-deficiency anemia in two separate study populations. The first study population consisted of a total of 34 apparently healthy females who were found to be anemic (Hb<125gL1) in a screening test. The anemic subjects were classified on the basis of plasma transferrin receptor (TfR) concentration into an iron-deficiency anemia group (TfR concentration 2.4mgL1, n=14) and an adequate iron stores group (TfR concentration <2.4mgL1, n=20). Another study population consisted of 95 hospital patients of whom 31 had depleted iron stores according to TfR concentration. The same population was classified further on the basis of hemoglobin value (Hb<125gL1 for females, Hb<135gL1 for males) into patients with iron-deficiency anemia (n=21) and those with anemia together with adequate iron stores (n=44). In the population of young anemic female students the percentage of hypochromic RBC (%HYPOm) had a remarkably high ROC AUC of 0.98 when evaluating the diagnostic accuracy for the distinction between the patients with iron-deficiency anemia and those with anemia and adequate iron stores. Also, among the hospitalized patients %HYPOm had the highest ROC AUC of 0.77. The diagnostic efficiency provided by the red blood cell and reticulocyte indices was considerably lower in the heterogeneous group of hospitalized patients than in the group of female students. Nevertheless, the advanced RBC and reticulocyte indices may prove to be useful tools in the evaluation of iron status and diagnosis of iron-deficiency anemia.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12068795&dopt=Abstract

Natural Herbal Supplement: Hair Million

Hair Loss, or alopecia is a concern for increasing number of folks in aging society. Loss of hair is a visible problem, and affects the appearance and changes identity of a person.
The phenomenon of hair thinning and hair loss is most commonly associated with natural aging, although there are many other causes of hair loss, which include inherited or genetic conditions, illnesses, malnutrition, stress, hormonal problems, chemotherapy, and use of some drugs.
Hair growth is a sophisticated biological process, which has not yet been completely understood. A multitude of therapeutic measures, including drugs, surgery, and suppelements have been made available, and used. However, due to the heterogeneity in the underlying cause, there is no perfect cure for all hair loss cases. Most of chemical drugs and hair transplantation surgeries are not free from varying degrees of undesirable side effects on health.

Hair Million is an alternative solution to hair loss problems. Anecdotally, it shows prositive results and improvement for age-related hair thinning and hair loss for a fraction of people who take it. We do not know the mechanisms of action as to how Hair Million works to help stop hair loss, and promote hair growth. We only know by anecdotal observations. There has been no clinical trials nor placebo controlled statistical analysis on the efficacy of Hair Million on hair loss and hair growth. However, there are two merits in this hair restoration herbal formula:
Firstly, Hair Million is rather inexpensive, and secondly, it is made of well known herbs that are safe when consumed in regular quantities.

DreamPharm Online Healthy Supplements || Constipation relief, laxative, colon cleansing || Lutein || Celexa Online || Paxil Online || Buspar Online || Tramadol Online || Flexeril Online || Natural herbal formula for hair loss problems ||